Mandate

Vinge advises Karolinska Development in connection with the company's listing on NASDAQ OMX

March 31, 2011

Vinge advises Karolinska Development AB (publ) in connection with the company’s new issue of shares of series B and listing of shares of series B on NASDAQ OMX Stockholm. First day of trading is expected to be 15 April 2011.

Vinge’s team consists of partner in charge Pontus Enquist as well as Emil Hedberg and Christoffer Benninge. In addition, Maria Schultzberg, Johanna Bergström and Maria Doeser (tax) as well as Claes Henriksson (IP), among other, have participated.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025